J&J’s Third-Quarter Profit Beats Estimates on Drug Sales

J&J’s Third-Quarter Profit Beats Estimates on Drug Sales

Daniel Acker/Bloomberg

Johnson & Johnson raised its 2012 earnings forecast to $5.05 to $5.10 a share excluding certain items, after trimming the forecast last quarter by 5 cents to $5 to $5.07 a share.